Mission BioCapital
Investor profile
Venture capital
Deals
3
distinct rounds
Companies
2
backed
Active span
2022–2024
3 yrs
Total round €
€153M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Immunos Therapeutics | Switzerland | 2 | €78M |
| Ambagon Therapeutics | Netherlands | 1 | €75M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Ambagon Therapeutics | Series A | €75M | 2022-01 |
| Immunos Therapeutics | Series B | €68M | 2022-06 |
| Immunos Therapeutics | Series C | €9.9M | 2024-09 |